Lilly Strattera Long-Term Efficacy Studies To Be Completed In 2003
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Lilly expects to complete two postmarketing studies assessing long-term efficacy of its attention deficit/hyperactivity disorder drug Strattera by the end of 2003.